Pick of the Week: GR Infraprojects Ltd - 26th April, 2025
Its project portfolio is diverse, encompassing railway overbridges, elevated metro lines, transmission lines, multi-modal logistics parks, and...
212 Views
Anthem Biosciences Pre-IPO - The Negatives- Margins Aren't There Yet
Anthem Biosciences is looking to raise up to US$400m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.
481 Views
G R Infraprojects - Execution Weak; Order Pipeline Remains Strong
EBITDA margin stood at 12.8% (+20bp YoY/+240bp QoQ) vs. our estimate of 12.5%. EBITDA declined 16% YoY to INR1.9b (9% below our estimate). EBITDA...
239 Views
GR Infraprojects Ltd - Robust & Diversified Orderbook to Drive Growth
Robust order book: The company's order book position, including L1 projects, stands at Rs 19,971 Cr, providing revenue visibility for the next 24...
257 Views
G R Infraprojects - Sharp Fall in Execution Dents Earnings
G R Infraprojects (GRINFRA)’s revenue declined 28% YoY to ~INR11.3b during 2QFY25 (vs. our estimate of INR16.8b). GRINFRA faced a slowdown in...
269 Views